Delanzomib
| CAS No. | 847499-27-8 |
|---|---|
| MDL No. | MFCD18251439 |
| MF | C21H28BN3O5 |
| MW | 413.30 |
| InChI Key | SJFBTAPEPRWNKH-CCKFTAQKSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Delanzomib is a C-terminal boronic acid peptide inhibitor that induces apoptosis in multiple myeloma, hematological, and solid tumor cell lines. It functions as a proteasome inhibitor, apoptosis inducer, and antineoplastic agent. It is a threonine derivative, phenylpyridine, C-terminal boronic acid peptide, and secondary alcohol, with functional similarity to L-threonine.
| CAS No. | 847499-27-8 |
|---|---|
| Product Name | Delanzomib |
Associated Conditions
multiple myeloma
* The information provided here is compiled from public sources and is for reference only.